Publication:
Editorial: Mechanisms and New Targets for the Treatment of Chronic Pain.

dc.contributor.authorNieto, Francisco Rafael
dc.contributor.authorVuckovic, Sonja Maksim
dc.contributor.authorProstran, Milica S
dc.date.accessioned2023-02-09T09:45:29Z
dc.date.available2023-02-09T09:45:29Z
dc.date.issued2020-09-16
dc.description.abstractNociceptive pain has a physiological protective role in preventing tissue injury. However, pain can become chronic due to a multitude of pathophysiological states, such as: inflammation, nerve injury, tumors, infections, autoimmune diseases, and vascular and metabolic disorders. These pathological states can trigger alterations of the pain pathways that can lead to painful hypersensitivity, and in such circumstances, pain loses its protective role and instead, becomes chronic, pathologic, and it can be extremely debilitating for people who suffer from it (Basbaum et al., 2009). Chronic pain has recently been defined as pain that persists or recurs for more than 3 months (Treede et al., 2019)
dc.description.versionSi
dc.identifier.citationNieto FR, Vuckovic SM, Prostran MS. Editorial: Mechanisms and New Targets for the Treatment of Chronic Pain. Front Pharmacol. 2020 Sep 29;11:600037. doi: 10.3389/fphar.2020.600037.
dc.identifier.doi10.3389/fphar.2020.600037
dc.identifier.issn1663-9812
dc.identifier.pmcPMC7550778
dc.identifier.pmid33117184
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550778/pdf
dc.identifier.unpaywallURLhttps://www.frontiersin.org/articles/10.3389/fphar.2020.600037/pdf
dc.identifier.urihttp://hdl.handle.net/10668/16497
dc.journal.titleFrontiers in pharmacology
dc.journal.titleabbreviationFront Pharmacol
dc.language.isoen
dc.organizationHospital Universitario San Cecilio
dc.organizationHospital Universitario Virgen de las Nieves
dc.organizationInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA)
dc.page.number4
dc.publisherFrontiers Research Foundation
dc.pubmedtypeEditorial
dc.relation.publisherversionhttps://doi.org/10.3389/fphar.2020.600037
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectanalgesics
dc.subjectcancer-related pain
dc.subjectchronic pain
dc.subjectmusculoskeletal pain
dc.subjectneuropathic pain
dc.subjectpain
dc.subjectpersistent pain
dc.subjectvisceral pain
dc.subject.decsDolor crónico
dc.subject.decsDolor nociceptivo
dc.subject.decsEnfermedades metabólicas
dc.subject.decsEnfermedades del sistema nervioso periférico
dc.subject.decsInflamación
dc.subject.decsNeoplasias
dc.subject.meshChronic Pain
dc.subject.meshPeripheral Nervous System Diseases
dc.subject.meshNociceptive Pain
dc.subject.meshMetabolic Diseases
dc.subject.meshNeoplasms
dc.subject.meshInflammation
dc.titleEditorial: Mechanisms and New Targets for the Treatment of Chronic Pain.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number11
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC7550778.pdf
Size:
234.51 KB
Format:
Adobe Portable Document Format